blindness

Researchers use retinal organoids to screen drugs and hope to transplant them into the eyes of people with blindness in the coming years.

In diabetic macular edema, senescent cells build up in the retina, leading to vision loss. A new drug forces these undead cells to die, healing the retina.

Eye injections are the only way to treat diabetic retinopathy, but many refuse to get them. Now, eye drops and pills are on their way.

Neuroscientists safely delivered a critical gene that improved vision for two patients with Leber congenital amaurosis.

Researchers are developing gene and cell therapies and prosthetics to help patients with blindness regain some vision. The first major prosthetic, the Argus II, was just discontinued. Where will the field go from here?